ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2524

Application of The 2012 Systemic Lupus International Collaborating Clinics Classification Criteria On a Regional Swedish Systemic Lupus Erythematosus Register

Anna Ighe1, Örjan Dahlström2, Thomas Skogh1 and Christopher Sjöwall1, 1Deparment of clinical and experimental medicine, Linköping University, Linköping, Sweden, 2Department of behavioural sciences and learning, Linneaus Centre HEAD, Swedish Institute for Disability Research, Linköping, Sweden

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: ACR, classification criteria and systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Systemic Lupus Erythematosus-Clinical Aspects III: Biomarkers, Quality of Life and Disease Indicators, Late Complications

Session Type: Abstract Submissions (ACR)

Background/Purpose: In addition to the 1982 American College of Rheumatology criteria (ACR-82) for scientific classification of systemic lupus erythematosus (SLE), many clinicians find the ‘Fries criteria’ (requiring an abnormal ANA titer plus at least two typical organ manifestations) helpful for diagnostic purposes. Last year, the Systemic Lupus International Collaborating Clinics group proposed a new set of validated classification criteria (SLICC-12), claimed to being more sensitive for SLE. The aim of the present study was to analyze the performance of SLICC-12 compared to Fries criteria and ACR-82 among well-characterized SLE cases and controls in a regional Swedish register.

Methods: The study population consisted of 231 SLE cases (93% Caucasians; 203 women, 28 men; mean age at diagnosis 38.8 years, range 3-85) confirmed by Fries criteria and/or ACR-82. 53 controls (46 women, 7 men; mean age 40.8 years; range 12-83 years) were enrolled on the basis of referral to a rheumatology specialist based on at least one criterion regarding ‘immunologic disorder’ according to ACR-82 and a clinical suspicion of SLE. Sensitivity and specificity figures for SLE were calculated. All confirmed SLE cases took part in a prospective follow-up programme at the Rheumatology clinic, Linköping University hospital. Informed consent was obtained from all subjects and the research protocol was approved by the Regional Ethics Committee in Linköping (M75-08). The controls were eventually diagnosed with the following conditions: SLE, rheumatoid arthritis, palindromic rheumatism, undifferentiated arthritis, pleuritis, undifferentiated connective tissue disease, primary antiphospholipid syndrome, scleroderma, polymyositis, fibromyalgia, primary Sjögren’s syndrome, psoriatic arthritis, PAPA syndrome, renal infarction, mixed connective tissue disease, Muckle-Wells syndrome, arthralgia, multiple sclerosis and overlap syndrome.

Results: Of the confirmed SLE cases, 98% fulfilled Fries criteria, 81% ACR-82 and 91% SLICC-12. The combinations of Fries and/or SLICC-12 identified 99%, compared to 93% of all confirmed SLE cases identified by ACR-82 and/or SLICC-12. The sensitivity was high for Fries (97%) and SLICC-12 (91%), but lower for ACR-82 (79%), whereas the specificity was superior for ACR-82 (98%) compared to Fries (83%) and SLICC-12 (75%).

Conclusion: We confirm that the ACR-82 criteria set offers a very high diagnostic specificity, but fail to reveal >20% of the SLE cases as defined here. The SLICC-12 criteria provide important additional sensitivity, whereas the specificity was mediocre in this comparison. To increase sensitivity and specificity figures, we advice a combination of the ACR-82 and SLICC-12 criteria for future SLE studies.


Disclosure:

A. Ighe,
None;

Dahlström,
None;

T. Skogh,
None;

C. Sjöwall,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/application-of-the-2012-systemic-lupus-international-collaborating-clinics-classification-criteria-on-a-regional-swedish-systemic-lupus-erythematosus-register/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology